Trial Profile
A retrospective study of velaglucerase alfa using whole-body magnetic resonance imaging in patients with Gaucher type 1 disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2016
Price :
$35
*
At a glance
- Drugs Velaglucerase alfa (Primary)
- Indications Gaucher's disease type I
- Focus Therapeutic Use
- 29 Nov 2016 New trial record